|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Birchview Capital LP
✚
|
|
|---|---|
| CRD # | 170534 |
| SEC # | 801-79710 |
| CIK # | 0001618205 |
| AUM | $183.1 M (2025-03-28) |
| Employees | 5 (80% Investors, 0% Brokers) |
| Phone | 802-923-3826 |
| Address | 688 Pine Street Burlington, VT 05401 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Bristol Myers Squibb Co | 15.0 | ||
| KLA Tencor Corp | 14.2 | ||
| Corcept Therapeutics Inc | 4.9 | ||
| Quidelortho Corp | 4.7 | ||
| Ovintiv Inc | 4.1 | ||
| Acadia Pharmaceuticals Inc | 4.1 | ||
| Neurocrine Biosciences Inc | 3.9 | ||
| Phreesia Inc | 3.3 | ||
| Prothena Corp PLC | 2.7 | ||
| Protagonist Therapeutics Inc | 2.7 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Monteris BC Holdings 6 LLC | [2023-03-22] | 1.5 | 3.1 |
| PE | Monteris BC Holdings 7 LLC | [2023-03-22] | 5.5 | 4.5 |
| PE | Birchview Capital VF III LLC | [2021-09-29] | 3.5 | 4.5 |
| PE | Monteris BC Holdings 5 LLC | [2021-03-30] | 29.7 | 4.2 |
| PE | Monteris BC Holdings 4 LLC | [2020-06-12] | 3.0 | 0.0 |
| PE | Ed BC Holdings 3 LLC | [2020-03-30] | 8.1 | 0.0 |
| PE | Monteris BC Holdings 3 LLC | [2019-03-20] | 6.6 | 0.0 |
| PE | Monteris BC Holdings 2 LLC | [2017-08-24] | 4.3 | 0.0 |
| PE | Ed BC Holdings LLC | [2017-03-31] | 0.6 | 0.0 |
| PE | Monteris BC Note LLC | [2017-03-31] | 6.2 | 0.0 |
| PE | Monteris BC Holdings LLC | [2016-03-28] | 24.5 | 0.0 |
| HF | Birchview Fund LLC | [2014-04-29] | 20.0 | 66.9 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.8 |
| (b) Individuals (high net worth individuals) | 0 | 99.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 12 | 83.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 16 | 183.1 |
| By Discretionary | ||
| Discretionary | 16 | 183.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 16 | 183.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 183.1 | |
| Total | 16 | 183.1 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Jack Schuler | 45 | ||
| Matthew Strobeck | 36 | ||
| Birchview Capital LP | 9 | ||
| Richard McCormick | 6 | ||
| Birchview Partners LLC | 2 | ||
| William Scully | 1 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001618205] | |
| 3 | [0001618205] | |
| 4 | [0001618205] | |
| SC 13G | [0001618205] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Birchview Capital LP | Aziyo Biologics Inc | [2021-12-17] |
| Birchview Capital LP | Soleno Therapeutics Inc | [2017-12-26] |
| Birchview Capital LP | Hansen Medical Inc | [2015-03-19] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| Elutia Inc | |
| Birchview Fund LLC | |
| Strobeck Matthew | |
| Birchview Capital, LP | |
| Birchview Partners, LLC | |
| Birchview Capital GP, LLC | |
| Yield10 Bioscience Inc |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Perini Capital LLC
✚
|
AZ | 0.2 |
|
MB Family Advisors LLC
✚
|
NY | 0.2 |
|
Maqro Advisors LLC
✚
|
TX | 0.2 |
|
Blackgold Capital Management LP
✚
|
TX | 0.2 |
|
Welcy Capital Advisors LLC
✚
|
FL | 0.2 |
|
Hayden Harper Wealth Advisory LLC
✚
|
NC | 0.2 |
|
Open Field Capital LLC
✚
|
NY | 0.2 |
|
Season Investments LLC
✚
|
0.1 | |
|
CIG Asset Management Inc
✚
|
MI | 0.1 |
|
South Georgia Capital LLC
✚
|
IL | 0.1 |